Contact Info Martha Nolte Kennedy, MD Endocrinology/Metabolism 400 Parnassus Avenue Ste 586A, Box 1222 San Francisco, CA 94143 Tel: (415) 353-2350 Fax: (415) 353-2337 Email: noltem@medicine.ucsf.edu

Associate Clinical Professor

Dr. Kennedy attended Wellesley College, and received her medical degree at the Medical College of Pennsylvania. She received internship training at Grady Memorial Hospital in Atlanta, Georgia, and had an additional two years or residency training at the University of Pittsburgh in Pittsburgh, Pennsylvania. Endocrine and Metabolism (Diabetes) fellowship training was taken at the University of California, San Francisco.
Dr. Kennedy began working in the field of Diabetes at the University of California, San Francisco in 1981 when she was a “Dorothy Frank Diabetes Fellow.” Dr. Kennedy has split her time between clinical research trials, seeing patients, and training the students. She currently is an Associate Clinical Professor of Medicine and became the Co- Director of the UCSF Diabetes Teaching Center in 1989, and Medical Director in 1994. She is Co-Director of the Diabetes Insulin Pump and Diabetes Clinics.

Overview of Research Activities

Dr. Kennedy has conducted trials examining the safety and clinical effect of novel therapies to treat diabetes and prevent complications. Currently research focuses on the relationship of diabetic neuropathy to autoimmunity which is when the body attacks itself, and possible mechanisms of the reduced bone density seen in individuals with type 1 diabetes.

Overview of Clinical responsibilities

Patient care is an important part of Dr. Kennedy’s professional activities. She sees patients in the Diabetes Teaching Clinics, Faculty Practice, and in the context of the UCSF Diabetes Teaching Center. Expanding availability of patient -management education is a major interest and commitment; Dr. Kennedy is developing patient education materials that will be internet based.

Selected Publications:

Nolte, M., Karam, J.H: Pancreatic Hormones & Antidiabetic Drugs.  Basic & Clinical Pharmacology, Ed. Bertram G. Katzung, 8th Edition. Lange/McGraw Hill 2004.

Gehi, A.,Webb, A., Nolte,M., Davis,J.:Case Report: Treatment of Systemic Lupus Erythematosus associated with Type B Insulin Resistance Syndrome with Cyclophosphamide and Mycophenolate Mofetil. Arthritis and Rheumatism 48:1067, 2003.

Rol, U., Turck, C.W., Gitelman, S.E., Rosenthal, S.M., Nolte, M.S., Masharani, U., Ziegler, A.G., Baekkeskov, S.: Peptide mapping and characterization of glycosylation patterns of the glima 38 antigen recognized by autoantibodies in Type I diabetes patients.  Diabetologia 43: 598, 2000.

Klonoff, D.L., Barrett, B.J., Nolte, M.S., Cohen, R.M., Wyderski, R.: Hypoglycemia Following Inadvertently and Advertently Unreported Sulfonylurea Overdosages.  Diabetes Care 18:563, 1995.

Nolte, M.S., “Insulin Therapy in Insulin Dependent (Type I) Diabetes Mellitus” in Endocrinology and Metabolism Clinics of North America.  June, 1992, p. 281 – 305.